Dare Bioscience, Inc. Increase (Decrease) in Other Accounts Payable
Dare Bioscience, Inc. (DARE) reported Increase (Decrease) in Other Accounts Payable of -$437.77 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-08-13
- Dare Bioscience, Inc. increase (decrease) in other accounts payable for the quarter ending 2026-06-30 was -$392.99K.
- Dare Bioscience, Inc. increase (decrease) in other accounts payable for the quarter ending 2026-03-31 was -$44.78K.
- Dare Bioscience, Inc. increase (decrease) in other accounts payable for the quarter ending 2025-09-30 was $518.21K.
- Dare Bioscience, Inc. increase (decrease) in other accounts payable for the quarter ending 2025-06-30 was -$120.54K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month |
|---|---|---|---|
| 2026-06-30 | -$392.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$437.77K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | -$44.78K 10-Q · filed 2026-05-14 | ||
| 2025-09-30 | $518.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $397.67K derived: sum of 2 quarters · filed 2026-08-13 | $366.13K 10-Q · filed 2025-11-13 |
| 2025-06-30 | -$120.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$152.08K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | -$31.54K 10-Q · filed 2026-05-14 | ||
| 2024-09-30 | -$861.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$2.99M derived: sum of 2 quarters · filed 2025-11-13 | -$2.34M 10-Q · filed 2025-11-13 |
| 2024-06-30 | -$2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.48M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $654.96K 10-Q · filed 2025-05-13 | ||
| 2023-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.29M derived: sum of 2 quarters · filed 2024-11-14 | $2.96M 10-Q · filed 2024-11-14 |
| 2023-06-30 | $3.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $4.51M 10-Q · filed 2024-08-12 | |
| 2023-03-31 | $667.66K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |